225 related articles for article (PubMed ID: 9484506)
21. MEN 11270, A novel selective constrained peptide antagonist with high affinity at the human B2 kinin receptor.
Meini S; Quartara L; Rizzi A; Patacchini R; Cucchi P; Giolitti A; Calò G; Regoli D; Criscuoli M; Maggi CA
J Pharmacol Exp Ther; 1999 Jun; 289(3):1250-6. PubMed ID: 10336513
[TBL] [Abstract][Full Text] [Related]
22. Human vascular kinin receptors of the B2 type characterized by radioligand binding.
Gessi S; Rizzi A; Calò G; Agnello G; Jorizzo G; Mollica G; Borea PA; Regoli D
Br J Pharmacol; 1997 Dec; 122(7):1450-4. PubMed ID: 9421294
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis, structural studies, biological evaluation, and computational simulations of novel potent AT(1) angiotensin II receptor antagonists based on the 4-phenylquinoline structure.
Cappelli A; Pericot Mohr Gl Gl; Gallelli A; Rizzo M; Anzini M; Vomero S; Mennuni L; Ferrari F; Makovec F; Menziani MC; De Benedetti PG; Giorgi G
J Med Chem; 2004 May; 47(10):2574-86. PubMed ID: 15115399
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and characterization of pseudopeptide bradykinin B2 receptor antagonists containing the 1,3,8-triazaspiro[4.5]decan-4-one ring system.
Mavunkel BJ; Lu Z; Goehring RR; Lu S; Chakravarty S; Perumattam J; Novotny EA; Connolly M; Valentine H; Kyle DJ
J Med Chem; 1996 Aug; 39(16):3169-73. PubMed ID: 8759638
[TBL] [Abstract][Full Text] [Related]
25. Discovery of the first non-peptide full agonists for the human bradykinin B(2) receptor incorporating 4-(2-picolyloxy)quinoline and 1-(2-picolyl)benzimidazole frameworks.
Sawada Y; Kayakiri H; Abe Y; Mizutani T; Inamura N; Asano M; Hatori C; Aramori I; Oku T; Tanaka H
J Med Chem; 2004 May; 47(11):2853-63. PubMed ID: 15139763
[TBL] [Abstract][Full Text] [Related]
26. Effects of a nonpeptide bradykinin B2 receptor antagonist, FR167344, on guinea-pig tracheal smooth muscle bradykinin receptors.
Asano M; Sawai H; Hatori C; Inamura N; Fujiwara T; Nakahara K
Can J Physiol Pharmacol; 1998; 76(10-11):1051-5. PubMed ID: 10100888
[TBL] [Abstract][Full Text] [Related]
27. Structure-activity relationships of novel peptide agonists of the human bradykinin B2 receptor.
Bélanger S; Bovenzi V; Côté J; Neugebauer W; Amblard M; Martinez J; Lammek B; Savard M; Gobeil F
Peptides; 2009 Apr; 30(4):777-87. PubMed ID: 19111586
[TBL] [Abstract][Full Text] [Related]
28. From bradykinin B2 receptor antagonists to orally active and selective bradykinin B1 receptor antagonists.
Barth M; Bondoux M; Luccarini JM; Peyrou V; Dodey P; Pruneau D; Massardier C; Paquet JL
J Med Chem; 2012 Mar; 55(6):2574-84. PubMed ID: 22369198
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis, and structure-activity relationship studies of novel 1-[(1-acyl-4-piperidyl)methyl]-1H-2- methylimidazo[4,5-c]pyridine derivatives as potent, orally active platelet-activating factor antagonists.
Carceller E; Merlos M; Giral M; Balsa D; García-Rafanell J; Forn J
J Med Chem; 1996 Jan; 39(2):487-93. PubMed ID: 8558517
[TBL] [Abstract][Full Text] [Related]
30. Effects of a nonpeptide bradykinin B2 receptor antagonist, FR167344, on different in vivo animal models of inflammation.
Asano M; Hatori C; Inamura N; Sawai H; Hirosumi J; Fujiwara T; Nakahara K
Br J Pharmacol; 1997 Dec; 122(7):1436-40. PubMed ID: 9421292
[TBL] [Abstract][Full Text] [Related]
31. In vitro studies of a bradykinin B1/B2 antagonist linked to a human neutrophil elastase inhibitor; a heterodimer for the treatment of inflammatory disorders.
Leimer AH; Kroona HB; Blodgett JK; Whalley ET; Ross SE; Burkard MR; Zuzack JS; Gernert DL; Dyckes DF
Can J Physiol Pharmacol; 1997 Jun; 75(6):633-8. PubMed ID: 9276141
[TBL] [Abstract][Full Text] [Related]
32. Solution-phase combinatorial synthesis of nonpeptide bradykinin antagonists.
Kam YL; Rhee SJ; Choo HY
Bioorg Med Chem; 2004 Jul; 12(13):3543-52. PubMed ID: 15186838
[TBL] [Abstract][Full Text] [Related]
33. Discovery of orally active nonpeptide bradykinin B2 receptor antagonists.
Asano M; Inamura N; Hatori C; Sawai H; Fujiwara T; Abe Y; Kayakiri H; Satoh S; Oku T; Nakahara K
Immunopharmacology; 1999 Sep; 43(2-3):163-8. PubMed ID: 10596849
[TBL] [Abstract][Full Text] [Related]
34. Highly selective bradykinin agonists and antagonists with replacement of proline residues by N-methyl-D- and L-phenylalanine.
Reissmann S; Schwuchow C; Seyfarth L; Pineda De Castro LF; Liebmann C; Paegelow I; Werner H; Stewart JM
J Med Chem; 1996 Feb; 39(4):929-36. PubMed ID: 8632416
[TBL] [Abstract][Full Text] [Related]
35. A new class of nonpeptide bradykinin B(2) receptor ligand, incorporating a 4-aminoquinoline framework. Identification of a key pharmacophore to determine species difference and agonist/antagonist profile.
Sawada Y; Kayakiri H; Abe Y; Mizutani T; Inamura N; Asano M; Aramori I; Hatori C; Oku T; Tanaka H
J Med Chem; 2004 May; 47(10):2667-77. PubMed ID: 15115408
[TBL] [Abstract][Full Text] [Related]
36. Kinin B2 receptor-mediated contraction of tail arteries from normal or streptozotocin-induced diabetic rats.
Wang Z; Wu L; Wang R
Br J Pharmacol; 1998 Sep; 125(1):143-51. PubMed ID: 9776354
[TBL] [Abstract][Full Text] [Related]
37. Discovery and evaluation of a series of 3-acylindole imidazopyridine platelet-activating factor antagonists.
Curtin ML; Davidsen SK; Heyman HR; Garland RB; Sheppard GS; Florjancic AS; Xu L; Carrera GM; Steinman DH; Trautmann JA; Albert DH; Magoc TJ; Tapang P; Rhein DA; Conway RG; Luo G; Denissen JF; Marsh KC; Morgan DW; Summers JB
J Med Chem; 1998 Jan; 41(1):74-95. PubMed ID: 9438024
[TBL] [Abstract][Full Text] [Related]
38. New conformationally homogeneous beta-turn antagonists of the human B2 kinin receptor.
Monteagudo ES; Calvani F; Catrambone F; Fincham CI; Madami A; Meini S; Terracciano R
J Pept Sci; 2001 May; 7(5):270-83. PubMed ID: 11428548
[TBL] [Abstract][Full Text] [Related]
39. Effects of an orally active non-peptide bradykinin B2 receptor antagonist, FR173657, on plasma exudation in rat carrageenin-induced pleurisy.
Majima M; Kawashima N; Hiroshi I; Katori M
Br J Pharmacol; 1997 Jun; 121(4):723-30. PubMed ID: 9208140
[TBL] [Abstract][Full Text] [Related]
40. LF 16.0335, a novel potent and selective nonpeptide antagonist of the human bradykinin B2 receptor.
Pruneau D; Luccarini JM; Fouchet C; Defrêne E; Franck RM; Loillier B; Duclos H; Robert C; Cremers B; Bélichard P; Paquet JL
Br J Pharmacol; 1998 Sep; 125(2):365-72. PubMed ID: 9786510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
